Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Monte Rosa Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering novel, small-molecule precision medicines.

52W Range

41stpctl

Volume

0.72×avg

Market Cap

1.13BUSD

P/E Ratio

-6.6TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Monte Rosa Therapeutics, Inc.

GLUENASDAQ Global Select·USD·Closed

Monte Rosa Therapeutics, Inc.

GLUENASDAQ·USD·Closed

$13.38

−6.56%

$13.38

−$0.94 (6.56%)

52W Range

41stpctl

Volume

0.72×avg

Mkt Cap

1.13BUSD

P/E

-6.6TTM

Div Yield

–ann

GLUE: Monte Rosa Therapeutics, Inc. Stock Analysis | finqOS